CAPhO 2026 Bridging to Better Outcomes: Empowering Oncology Pharmacists in Adjuvant CDK4/6 Inhibitor Management

Novartis Sponsored Symposium

Join experts as they review current evidence and guidelines in early breast cancer, develop practical strategies to manage adverse events, drug interactions, and adherence, and explore real-world models demonstrating the impact of pharmacist-led care. Attendees will leave equipped with actionable insights to strengthen their role within multidisciplinary oncology teams and optimize patient outcomes.